Graphical abstract
Keywords: COVID-19, Coronavirus, Wastewater treatment plant, Detection, Virus concentration, Wastewater-based epidemiology
Abstract
Currently, SARS-CoV-2 has been detected in the influent of wastewater treatment plants (WWTP), pumping stations, manholes, sewer networks and sludge of WWTP and facilities of countries as France, Spain, Italy, Netherlands, United States, Australia, Ecuador, Brazil and Japan. Although this virus has been detected in the wastewater streams, there is no robust method for its detection and quantification in wastewater. This review compiled and analyzed the virus concentration approaches applied to detect the SARS-CoV-2, besides to provide insights about the methodology for viral concentration, limit of detection, occurrence, persistence, and perspectives post-COVID-19 related with the implications of the virus presence in wastewater. The SARS-COV-2 detection in wastewater has been related to virus concentration methods, which present different recovery rates of the virus. The most used viral concentration methods have been the polyethylene glycol (PEG) for precipitation of viral material and the ultrafiltration at molecular weight level. After viral concentration, the detection and quantification of SARS-COV-2 in wastewater are mainly via quantitative reverse transcription polymerase chain reaction (RT-qPCR), which is the clinical assay adapted for environmental purposes. Although in some experiments the positive control during RT-qPCR is running a surrogated virus (e.g., Mengovirus or Dengue virus), RT-qPCR or reverse transcription droplet digital PCR (RT-ddPCR) targeting the gene encoding nucleocapsid (N1, N2 and N3) of SARS-COV-2 are highly recommended to calculate the limit of detection in wastewater samples. Current results suggest that a rigorous methodology to elucidate the positive cases in a region from genomic copies in wastewater is needed.
1. Introduction
The disease caused by the new coronavirus SARS-CoV-2 is officially called COVID-19, which has caused a pandemic worldwide with deep impacts on aspects of human life [1]. Currently (October 1st, 2020), there are 33,842,281 confirmed cases for COVID-19 around the world, and 1,010,634 accumulated deaths in 188 territories [1]. The high rate of infected people, the longtime that takes for the human host to develop antibodies against the virus [2], and the mortality rate [3] are characteristics of the COVID-19, which are not common in some other viral diseases.
Detection of SARS-CoV-2 in the sewer networks is essential in the initial stages of community spread. Moreover, early detection in a community reduces the rate of contagion and prevents over-saturation of health systems. At this time, the most common tests to diagnose a person with COVID-19 are chest computed tomography (CT) and quantitative reverse-transcription polymerase chain reaction (RT-qPCR). This last test is based on the multiplication of nucleic acids present in the virus, which make the test accurate due to it confirms the genetic presence of SARS-CoV-2 in a person, a medium or an object. Moreover, applying RT-qPCR can be quantified the genomic units of SARS-CoV-2. This assay is performed to detect different regions of the SARS-CoV-2 genome in human fluids such as rhino-pharyngeal, oropharyngeal, as well as fecal samples, surfaces and wastewater. The genetic regions of SARS-CoV-2 detected include the envelope protein gene (E gene), nucleocapsid protein gene (N gene), or RNA-dependent RNA polymerase gene (RdRp gene) [4,5]. Comparative assays among different primer-probe sets from those genes showed to be highly specific with no false-positive, but with different sensitivities regarding to the quantitative presence and fluids [6]. The reverse transcription droplet digital PCR (RT-ddPCR) is another technique which has also been applied to quantify the SARS-CoV-2 in wastewater [[7], [8], [9]]. In terms of sensitivity, Falzone et al. [10] found that the ddPCR technique has shown higher sensitivity and specificity compared to RT-qPCR for the diagnosis of COVID-19 in false-negative rhino-pharyngeal swab samples with low viral load.
The persistence of SARS-CoV-2 in humans includes its presence in fluids such as urine [11] and feces [[12], [13], [14]] that arrive to the wastewater streams by these excretions. In a recent study, it was reported that SARS-CoV-2 presence is more common in feces than in urine [15], hence stool can be considered as main contributor of genomic units of the virus in the wastewater streams. Indistinctly to the source of the excretion of the virus, its detection in wastewater streams via surveillance of wastewater is an opportunity to track the pandemic in a covered area by monitoring the sewer networks, which may potentially prevent a fast spread of the COVID-19 [16,17]. In fact, surveillance of wastewater streams can be considered as an early warning tool. This approach is known as wastewater-based epidemiology (WBE), which has been proposed for surveillance of viral diseases such as poliovirus, and to track the use of illicit drugs in a determined area [18,19]. Currently, nearly a dozen research groups around the world have performed tests to detect the presence of SARS-CoV-2 in wastewater [20]. Their findings have confirmed the presence of the virus in wastewater, and in some cities, the SARS-CoV-2 has been detected in wastewater before confirming the first case by the health authorities [21].
From the wastewater treatment point of view, the road map will include the next milestones: i) The development of robust methodologies for the detection of SARS-COV-2 in wastewater, ii) Application of wastewater-based epidemiology (WBE) as a COVID-19 monitoring tool, iii) Analysis and response for possible impacts on the WWTP operation (process and technology), and iv) Development of protocols to response to the new diseases (including virus or bacterial pandemics). This review is focused on the first milestone, but the WBE and wastewater treatment post-COVID-19 are also reviewed.
The systematic detection of the SARS-CoV-2 in wastewater is needed to set the WBE, which can provide useful information on the level of spread of COVID-19 in a community. In addition to the research needs on the subject of detection of SARS-CoV-2 already compiled by Kitajima et al. [17], and research needs about of SARS-CoV-2 in the public health already reported by Farkas et al. [16], there is a basic research need for selecting the most suitable method for viral concentration in wastewater prior its detection by molecular techniques based on PCR. The concentration of virus in wastewater samples provides higher resolution when a molecular technique for detection is applied. Several studies reported, via formal peer-reviewed publication, the detection of SARS-CoV-2 in wastewater and related their findings to the epidemiological behavior. However, the methodologies applied to detect the virus have not been standardized in a robust one. Hence, to generate a robust method for SARS-CoV-2 detection in wastewater, the methodologies applied for viral concentration before its detection must be analyzed in formal studies. Moreover, facing the new normality, perspectives about the presence on the virus in wastewater in a post-COVID-19 scenario are also demanded. This review compiles and analyze the SARS-COV-2 approaches and protocols for viral concentration, detection, occurrence and persistence in wastewater in order to provide insights and best practices, as well as needs and perspectives for the wastewater treatment post-COVID-19.
2. Detection of SARS-CoV-2 in wastewater
One of the major challenges in SARS-CoV-2 detection and quantification in wastewater samples is the lack of an optimized and standardized protocol [22]. However, there are overall considerations in the protocols already applied for the detection of SARS-CoV-2 in wastewater. These considerations can be categorized as steps for virus detection in wastewater, which include the sampling timing and conditions, virus inactivation (e.g. heat treatment, pasteurization of the sample), the correct use of protective equipment for virus handle, grit and solids removal in some samples, concentration of the virus, detection of the virus, and quantification of the genetic units of the virus. All these steps will be discussed in this section.
2.1. Sample collection, handling and storing of the wastewater samples
According to the population-based health management analysis proposed by Thompson et al. [23], the upstream sampling of multiple locations may provide higher spatial resolution related to positive cases per inhabitants, when compared to downstream sampling (e.g. influent of WWTP), which presents higher travel time of the wastewater and may present signal degradation. Although sample collection could be random through collection of single samples at an arbitrary time, the timing of sampling has influenced the detection of SARS-CoV-2 in wastewater. Sherchan et al. [24] found that the sampling method is critical, and that composite samples of 24 h may provide the most reliable daily average of viral concentration in wastewater. Moreover, sampling protocols should consider the inactivation time of the coronavirus in wastewater, that could be between 2.3 and 3.5 days at 23 °C [25]. However, the temperature during collection and preservation may play an important role in virus degradation. In recently reported studies, the preservation temperature of collected samples for has been 4 °C or -20 °C (Table 1 ), without a clear trend toward lower RNA signals when the samples are stored at 4 °C for almost two weeks [26]. Ahmed et al. [27] demonstrated that the SARS-CoV-2 RNA signal is unlikely to degrade significantly at the temperatures of storing (4 °C) for at least 10 d. Nevertheless, the decay in RNA signal is influenced by the temperatures (15 °C, 25 °C and 37 °C), water matrix (tap water or wastewater) and thermal treating of the samples by autoclaving [27]. Sherchan et al. [24] processed wastewater samples stored at -80 °C between 1 and 2 months before the pandemic, which tested negative since first case was reported a month later. Although the majority of samples are processed within 12 h after collection, reprocessing stored samples under different temperatures is needed in order to determine the potential bias in the detection and sensitivity during storage. Regarding the handling of samples potentially containing SARS-CoV-2, they should be handled according to the subsequent use of samples. For example, since infectious SARS-CoV-2 is classified as a biosafety level 3 (BSL-3), culturing of samples that potentially contain SARS-CoV-2 requires BSL-3 guidelines [4], nevertheless, procedures that concentrate viruses, such as precipitation or membrane filtration, can be performed in a BSL-2 laboratory with unidirectional airflow. Although there is no evidence that infectious SARS-CoV-2 is present in wastewater streams, samples can be submitted to heat treatment (e.g. 30 min at 60 °C) before opening containers to increase the safety of the workers who perform the analysis [28,29], since this procedure can inactivate the potentially infectious agents present in the samples. The effect of heat treatment of wastewater samples (e.g., pasteurization or autoclaving) on RNA signal intensity of coronaviruses is a topic with few insights and contradictory findings, that represents a research need. While the high persistence of RNA signal intensity of SARS-CoV-2 over time (up to 10 d) in autoclaved wastewater samples has been attributed to changes in the physicochemical characteristics of wastewater after the autoclaving them [27], the recovery rate of RNA of coronaviruses can decrease after heat treatment due to its weak resistance and high sensitivity to the environmental factors such as temperature [30] and chlorine ions [31], as well as to the presence of RNases which are present even in autoclaved samples [32]. In addition, special care must take into account during virus inactivation and virus concentration, some BSL-3 precautions are recommended. Some studies removed the grit and solids from the matrix before and after to viral RNA concentration and isolation from wastewater samples, which mainly consisted in two ways for removing larger and dense particles from wastewater (Table 1): filtration (0.45−0.20 μm) [33] and centrifugation [8,24,28]. It should be highlighted that when filtration and centrifugation are applied, the biomass retained in filters or pellets can be analyzed to quantify the presence of RNA, which will allow to consider that value for full quantitative purposes.
Table 1.
Summary of the methods used for SARS-CoV-2 detection in wastewater and its classification by virus concentration approach as Ultracentrifugation, Adsorption and precipitation, Polyethylene glycol (PEG) precipitation, Centrifugal ultrafiltration, and direct extraction.
| Concentration | RNA recovery | Quantification | Reference |
|---|---|---|---|
| Ultracentrifugation | |||
| Centrifugation (229 600 g, 1 h, 4 °C) | QIAamp Viran RNA Mini kit (Qiagen) | RT-qPCR | [29] |
| Adsorption and precipitation | |||
| pH adjustment (6.0 and AlCl3) + Mixing (150 rpm, 15 min) + Centrifugation (1700 g, 20 min) + Pellet resuspension (beef extract, shaking 10 min, 150 rpm) + Centrifugation (1900 g, 30 min) | Nucleo-Spin RNA virus kit (Macherey-Nagel GmbH & Co) | RT-qPCR | [21] |
| pH adjustment (3.5−4) + Filtration (0.45-μm, electronegative membrane) | RNeasy PowerWater Kit and RNeasy PowerMicrobiome Kit (Qiagen) | RT-qPCR | [27] |
| pH adjustment (3.5) + Pre-flocculation (1% w/w with skimmed milk) + Stirring (8 h) + Centrifugation (8000 g, 40 min) + Pellet resuspension (Phosphate buffer) | AccuPrep® Universal RNA Extraction Kit | RT-qPCR | [34] |
| Addition of MgCl2 + Filtration (0.8 μm) + Buffer addition + Centrifugation (2000 g, 10 min, 4 °C) + Filtration (0.45 μm) + Ultrafiltration (50 kDa) | QIAamp Viral RNA Mini Kit (Qiagen) + QIAcube automated platform (Qiagen) | RT-qPCR | [35] |
| Addition of MgCl2 + Filtration (0.45-μm, electronegative membrane) + Elution (1 mM NaOH) + Eluate recovering and neutralization (100 mM H2SO4, Tris-EDTA) + Ultrafiltration (30 kDa) | ZR Viral RNA Kit (ZymoResearch) | RT-qPCR | [24] |
| PEG precipitattion | |||
| Sample treatment (56 °C, 30 min) + Centrifugation + PEG-dextran (4 °C, in a separation funnel, overnight) | NucliSENS miniMAG (bioMerieux) + OneStep PCR Inhibitor Removal Kit (Zymo). | Reverse Transcription + nested PCR, RT-qPCR | [28] |
| Centrifugal ultrafiltration | |||
| Centrifugation (4654 g, 30 min) + Centrifugal ultrafiltration (1500 g, 15 min, 100 kDa) | RNeasy PowerMicrobiome Kit (Qiagen) or Biomerieux Nuclisens kit (Biomerieux) | RT-qPCR | [8] |
| Centrigugation (3000 g, 30 min) + Centrifugal ultrafiltration (1500 g, 15 min, 100 kDa) | ZR Viral RNA Kit (ZymoResearch) | RT-qPCR | [24] |
| Centrifugation (4750 g, 30 min) + Centrifugal ultrafiltration (3500 g, 15 min, 10 kDa) | N.D. | RT-qPCR | [27] |
| Direct extraction | |||
| Only filtration (0.7 μm and 0.2 μm) | Qiamp Viran RNA mini kit (Qiagen) | RT-qPCR | [33] |
N.D. Not Defined; > 70 % of studies report a 4 °C temperature of sample preservation, and processing time in less than 24−48 h after sampling.
2.2. Concentration of the virus in wastewater
The viral concentration is a key step for detection and quantification of SARS-CoV-2 in wastewater due to its concentration decreases by dilution in wastewater streams. The approaches applied for this purpose are multiple and include the one used for poliovirus concentration based on two-phase separation method [36], precipitation [21], centrifugation [37,38], ultrafiltration [8,38], conventional filtration [33] and filtration by negatively charged membranes [39], and a combination of these approaches (Table 1). Although there are efficient methods to concentrate enveloped virus such as coronaviruses from wastewater [40] and tap water [41], the specific efficiency in recovering SARS-CoV-2 may perform differently. Therefore, it is highly recommended to determine the recovery rate of the virus for the concentration method applied. In this review, the methods for SARS-CoV-2 concentration are grouped in two categories, the physicochemical based and the strictly physical based methods (Fig. 1 ). The physicochemical based methods incorporate the use of chemical reagents in some steps of physical separation for the extraction and concentration of the virus. Chemical reagents include the combined used of the polymer polyethylene glycol (PEG) with NaCl, dextran or alum, in order to perform a liquid-liquid fractionation (aqueous two-phase technique), with potential for the extraction, separation, purification, and enrichment of viruses. The miscibility of solutions containing polymers results in the formation of two phases, separating the solute selectively in one phase [42]. The use of Al(OH)3 and AlCl3 with pH adjustment by addition of HCl has been addressed in order to precipitate the viral content due to the modification of surface charge in the virus. In general, the incorporation of chemicals reagents considers reaction and incubation time, which even can be for overnight periods for phases separation (Fig. 1). Finally, the extraction and amplification of genetic information are performed in the extracted or precipitated phase. According to the reported studies, most of the physicochemical approaches for virus concentration take more time (up to 15.5 h) and they involve more steps than the strictly physical methods. Although the physicochemical based approaches can include some physical steps such as, filtration and centrifugation, their effectiveness for virus concentration is attributed to the chemical adsorption [36,43]. The strictly physical based methods for viral concentration mainly applied a combination of centrifugation and filtration or ultracentrifugation and resuspension (Fig. 1). Although the reported physical based protocols for SARS-CoV-2 concentration take less than 1.4 h to be completed, centrifugal ultrafilters with cut-off up to 100 kDa, units for centrifugation of high volume, equipment for ultracentrifugation or ultrafiltration units may be required.
Fig. 1.
Description of the methods applied for concentration of the SARS-CoV-2 present in the wastewater streams divided as physicochemical based (green boxes) and physical based virus concentration (orange boxes) methods. Blue circles were assigned to the steps with reported time to perform them. Red circles were assigned to steps without time reported to perform them. Concentration time is the sum of the time reported in all steps.
Some studies have tested the effectiveness of methods for viral concentration of SARS-CoV-2 in wastewater. Ahmed et al. [27] found inconsistent results in SARS-CoV-2 concentration and recovery when they compared the electronegative membranes with the ultrafiltration tubes with a cut-off at 10 kDa of molecular weight (MW). In the same study, it was used murine hepatitis virus (MHV) as surrogate of SARS-CoV-2 and it was found that adsorption-extraction methods for viral concentration could recover up to 65 % of MHV [43]. It is important to highlight that MHV and SARS-CoV-2 are enveloped virus from the same genus (Betacoronavirus) [44], share similar genomic structure and envelope glycoproteins spike [45]; hence, the recovery rates could be close between both virus, even though, as the recovery rate depends on the wastewater matrix, high recoveries may not be observed at all times, thus, variations on the recovery are expected. Randazzo et al. [21] validate the Al(OH)3 adsorption-precipitation method using Porcine Epidemic Diarrhea Virus (PEDV) and Mengovirus (MgV), reporting recovery efficiencies of 11 % of both virus in influent samples. In the same sense, using Mengovirus as surrogate virus, no significant loss of RNA was reported for heat-treating the wastewater samples [28]. Medema et al. [8] validated the purification and concentration steps using the ultrafiltration method (100 kDa membranes), reporting a recovery efficiency of 73 ± 50 % (n = 16) of F-specific RNA phages; meanwhile the RNA extraction and RT-qPCR steps showed a recovery efficiency of 30.4 ± 22.3 % using an internal control RNA. Validate the methods for SARS-CoV-2 concentration in wastewater is a current need for analytical protocols and to strengthen the wastewater-based epidemiology studies. Also, the need of reference materials for RT-qPCR quantification has been recommended, to allow intra and interlaboratory comparison of RT-qPCR results for SARS-CoV-2 surveillance in wastewater [8].
2.3. Detection and quantification of the virus
The method more used to detect and quantify the SARS-CoV-2 in wastewater has been RT-qPCR (Table 1), which is part of the second generation of PCR. Although this method can detect the regions ORF1a, ORF1b, E and N of the SARS-CoV-2 genome, N or nucleocapsids have been the most used target during assays after RNA extraction of viral concentrated from wastewater [8,46]. The commercial availability of nucleocapsids (N1 and N2) primer-probe sets has facilitated their use during detection assays in wastewater, even when some reagents for COVID-19 detection have limited availability to conduct tests [20]. Nucleocapsid region has also been used to determine the limit of detection (LOD) during quantitative analysis, that has ranged from 2 log10 [7] to 4.45 log10 copies per liter of wastewater [21]. These quantitative results for SARS-CoV-2 have been validated theoretically for LOD regarding to the spiked concentration. In addition to the quality controls to measure the recovery efficiency during the RNA concentration and isolation steps, some studies have included other controls during the quantification, as internal reference and indicators of PCR inhibition, like Sketa 22 assa (Oncorhynchus keta), and β-actin [39]. As well, human crAssphage was used by Green et al. [47] (pre-print) as internal control for normalizing SARS-CoV-2 concentration in wastewater samples. Similarly, pepper mild mottle virus has been used as internal control for detection of SARS-CoV-2 [35,48]. Since positives and internal control assays follow different targets, even with different nucleocapsids, the determination of limit of detection of SARS-CoV-2 in wastewater is unclear and not rigorous in terms of analytical protocols. The use of noninfectious SARS-CoV-2 or a positive fecal samples in wastewater in order to set the limit of detection and quantification of SARS-CoV-2 in wastewater could be an approach that increase the reliability of the quantitative methods [21].
Besides RT-qPCR, RT-ddPCR could be used to detect and quantify SARS-CoV-2 in wastewater Gonzalez et al. [7]. This last tool has presented higher sensitivity in human samples than RT-qPCR [10,49]. Gonzalez et al. [7] used a RT-ddPCR assay and determined theoretical LOD in wastewater of N1, N2, and N3, which were 14.6, 2, and 2.18 copies per reaction, respectively. The N2 assay results were used in the work performed by Gonzalez et al. [7] as they were the most sensitive, and presented SARS-CoV-2 concentrations in wastewater samples between 101 and 104 copies per 100 m L−1 during the 21-week study in Southeastern Virginia. In another study, Falzone et al. [10] performed a comparison between RT-qPCR and ddPCR sensivity in human positive rhino-pharyngeal swab samples and found that sensitivity of ddPCR permitted the identification of positive signals in undiluted samples and in the 10-fold dilution, demonstrating that ddPCR is effective in the detection of very low viral load. Although RT-ddPCR has been more sensitive in rhino-pharyngeal samples [10,49], research is needed to compare the sensitivity of various methods, including RT-qPCR and RT-ddPCR in wastewater samples. Table 2 shows the advantages and disadvantages of RT-ddPCR and RT-qPCR.
Table 2.
Comparison of limitations and benefits of RT-ddPCR and RT-qPCR techniques.
| Technique | Principle | Advantages | Disadvantages |
|---|---|---|---|
| RT-qPCR | Amount of amplified product is comparative to the fluorescence signal intensity. The sample is quantified using the reaction cycle threshold and standard curve [50]. | Extensive dynamic range, wide application range, low cost [50], rapidity of diagnosis, can be used to screen large numbers of samples, a run-time of approximately 90 min [51] | Amplification efficiency is susceptible to PCR inhibitors [50] |
| RT-ddPCR | Generates microreaction units with water-in-oil and microfluidic technology. The nucleic acids are randomly subdivided into water-in-oil droplets that undergo PCR separately [50]. | No external calibration curves are needed, and it may be less sensitive to inhibition and suboptimal PCR efficiency, high sensitivity, better resistance to PCR inhibitors, greater precision in quantification [52,50] | Narrow dynamic range and high cost [50] |
3. Occurrence of SARS-CoV-2 in wastewater
The virus that causes COVID-19 has been detected in the wastewater of several cities and regions around the world (Table 3 ). Although the majority of samples were collected at the influent of the WWTP, sampling points in the sewer network, manholes, hospital wastewater and pumping stations were also monitored to delimit the scope of the study. The sampling dates were different for all experiments but ranged from February 3rd to April 25th. For samples collected in some municipalities of Murcia, Spain, such as Lorca, Cieza, and Totana, positive results of SARS-CoV-2 in wastewater alerted COVID-19 cases 12–16 days before first cases were declared [21]. The same was reported for Amersfoort, Netherlands, where wastewater samples on March 5th resulted positive, few days before the first case in the city was confirmed [8]. These findings strongly suggest that surveillance of the untreated wastewater streams may contribute to monitoring the pandemic. However, the limited availability of the reagents for COVID-19 detection should be considered to avoid a shortage of the reagents for clinical purposes. Nonetheless, it is important to mention that reagents used for research are commonly tag as "research-use only” and they should not be utilized for clinical diagnose.
Table 3.
Detection and quantification of SARS-CoV-2 genes in wastewater and sludge from different locations of the world.
| Location | Sampling site | Inhabitants covered | Positive cases within sampling date | Gene quantified | Genetic concentration (genome units, gu, or genome copies, gc) | Ratio Samples positive/Samples analyzed | Reference |
|---|---|---|---|---|---|---|---|
| France | |||||||
| Paris | 3 WWTP | 100 000 | 90−11 200 | E gene | From: 5 × 104 gu /L (March, 05th) | Influent: 3/3 | [37] |
| To: 3 × 106 gu /L (April, 09th) | |||||||
| Spain | |||||||
| Murcia | 6 WWTP | 750 132 | 144−976 | N gene | On average, 5.1 ± 0.3, 5.5 ± 0.2, and 5.5 ± 0.3 log10 gc/L wastewater for N1, N2 and N3 primer mixes. | Influent: 35/42 Secondary effluent: 2/18 Tertiary effluent: 0/12 | [21] |
| Italy | |||||||
| Milan | 3 WWTP | 2 000 000 | 23,075 | ORF1ab, N and E genes | N.D. | Inffluent: 4/6 Effluent:0/6 | [33] |
| Milan | 2 WWTP | 2 100 000 | 29 | ORF1ab, S and RdRP | N.D. | Influent: 2/8 | [28] |
| Rome | 1 WWTP | 900 000 | 2 186 | ORF1ab, S and RdRP | N.D. | Influent: 4/4 | [28] |
| Netherlands | |||||||
| Amsterdam | 1 WWTP | 790 800 | 0−530* | N and E genes | 1.2 × 102 to 1.8 × 103 gc/mLb | Influent: 2/4 | [8] |
| Den Haag | 1 WWTP | 980,000 | 0−323* | N and E genes | 1.2 × 101 to 7.5 × 101 gc/mL | Influent: 3/5 | [8] |
| Utrecht | 1 WWTP | 371,000 | 0−289* | N and E genes | 1.2 × 101 to 1.3 × 103 gc/mL | Influent: 4/5 | [8] |
| Apeldoorn | 1 WWTP | 245,000 | 0−57* | N and E genes | 2.6 × 101 to 1.8 × 102 gc/mL | Influent: 2/4 | [8] |
| Amersfoort | 1 WWTP | 234,500 | 0−67* | N and E genes | 6.6 × 10° to 4.7 × 102 gc/mL | Influent: 3/4 | [8] |
| Tilburg | 1 WWTP | 262,500 | 0−317* | N and E genes | 2.7 × 102 to 2.7 × 102 gc/mL | Influent: 3/3 | [8] |
| Schiphol Airport | 1 WWTP | 54,000a | N.R. | N and E genes | 2.6 × 10° to 1.7 × 103 gc/mL | Influent: 3/4 | [8] |
| United States of America | |||||||
| Louisiana | 2 WWTP | 290 321 | 0−6173 | N gene | 3.1−7.5 gc/mL | Influent: 2/7 | [24] |
| Effluent: 0/8 | |||||||
| Ecuador | |||||||
| Quito | 1 SN | >10 000 | 358−2077 | N gene | 2.23 × 106 to 3.19 × 106 gc/L | Sewer: 1/1 | [34] |
| Australia | |||||||
| Brisbane | 1 PS 2 WWTP | 736 172 | 1−900 | N gene | 1.9 to 12 gc/100 m L | Pumping station: 0/1 Influent: 2/8 | [39] |
| Japan | |||||||
| Yamanashi | 1 WWTP | N.D. | 0−57 | N gene | Influent: 4.0 × 103–8.2 × 104 gc/L | Inffluent: 5/5 | [35] |
| Effluent: 1.4 × 102–2.5 × 103 gc/L | Effluent: 5/5c | ||||||
| Brazil | |||||||
| Niterói, Rio de Janerio | 2 WWTP 8 SN | N.R. | 0−70 | N gene | Ct 36.3–39.8 | Influent: 2/2 Sewer netwrok: 3/8 | [29] |
| 2 HW | Hospitals: 0/2 | ||||||
Sampling site: Wastewater treatment plant (WWTP), suburban pumping station (PS), Manhole (MH), Hospital wastewater (HW), and sewer network (SN); Positive cases within sampling date.
Calculated value from positive cases per 100 000 inhabitants; N.R. Not reported; N.D. Not Defined.
Design capacity.
Only for N genes quantification.
Before chlorination.
Although the SARS-CoV-2 has been detected in untreated wastewater, this virus has also been detected in 2/18 samples of treated effluent after wastewater passed throughout the activated sludge process as secondary treatment; moreover, all samples after tertiary treatment (e.g., coagulation-flocculation, UV or NaClO) resulted as negative [21]. This highlights the relevance of disinfection processes with physicochemical technologies as chlorine-based ones to eliminate the presence of genetic material of the virus, as previously reported for SARS-CoV [31]. Utilities appear to identify their important role in water treatment and disinfection [53]. Given that there is the possibility of finding SARS-CoV-2 RNA in the secondary effluent and considering that is unclear whether the virus is potentially infectious at this stage of treatment, a disinfection process is recommended for those systems with only secondary treatment to prevent the circulation of SARS-CoV-2 titers in secondary effluent water.
The presence of SARS-CoV-2 RNA in the primary sludge and waste activated sludge was recently detected in 7 WWTP of Istanbul, Turkey [54] (pre-print). Titers of SARS-CoV-2 RNA in primary sludge and waste activated sludge ranged from 1.17 × 104 to 4.02 × 104 per liter of sludge. These concentrations may vary depending on the solids concentration in samples and on the sources of the samples. For example, the of SARS-CoV-2 RNA copy number detected in the suspended solids of raw wastewater [55] were lower than those reported previously for waste sludge [54] (pre-print). Westhaus et al. [55] filtered 45 mL of raw wastewater and compared the SARS-CoV-2 RNA copy number present in the wastewater phase and in the pellet that resulted of the ultrafiltration by 10 kDa. The experiment indicated that the solid phase of samples of raw wastewater are one log unit higher of SARS-CoV-2 RNA copy number per mL (25 copies mL−1) than to the aqueous phase of the inflow sample (1.8 copies mL−1). Cheung et al. [56] detected SARS-CoV-2 RNA in fecal matter and found median fecal viral load of 5.1 log10 copies per mL in patients with diarrhea, while for patients without diarrhea was 3.9 log10 copies per mL. These results support that the titers of the virus could remain in the fecal matter and other suspended solids present in the wastewater. These findings also suggest the presence of titers of SARS-CoV-2 in the disposed sludge from WWTPs; hence, further disinfection of the waste sludge could be needed before sludge disposal while occurrence studies of the virus in the waste sludge are still under research. Nevertheless, comprehensive studies related to the fate of SARS-CoV-2 RNA in waste sludge, digested sludge or biosolids [57], as well as studies determining whether or not the virus in the sludge may be infectious are also needed.
4. Persistence of SARS-CoV-2 in wastewater
The environmental conditions (e.g., temperature, humidity, particulate material, among others) related to the SARS-CoV-2 spread have recently considered in some studies [22,25,58,59], since they affect the persistence of infectious SARS-CoV-2 and its RNA signal. The physicochemical conditions of the wastewater streams may influence the persistence of infectious SARS-CoV-2 and its RNA signal [60]. Some ions in the wastewater may alter the membrane protein of SARS-CoV-2 as ions altered the membrane of the SARS-CoV, which is a virus from the same subgenus (sarbecovirus) as SARS-CoV-2 and has hydrophobic and selective (for monovalent cations) membrane protein [61].
Although SARS-CoV-2 has been less resistant than bacteria to chlorine concentration in water [46], some coronavirus can persist in wastewater up to 3.5 days at 23 °C [25]. Wang et al. [31] suggest that SARS-CoV persists in fecal samples for 3 days and in urine samples for 17 days, and that SARS-CoV is more vulnerable to disinfectants than E. coli and f2 phage. Although this virus from the same subgenus than SARS-CoV-2 may persist for some time in water, the potential transmission of infectious SARS-CoV-2 through wastewater streams has not been confirmed [8,46]. It means that the detection of SARS-CoV-2 in wastewater does not imply that the virus is able to infect humans [62]. Since the transmission is linked to the viability of the virus in wastewater, research focused in virus stability in the environmental matrices, distinguishing infectious and noninfectious virus, and determination of the persistence factors of SARS-CoV-2 in wastewater are needed.
Regarding waste solids, SARS-CoV RNA has been detected in the feces of infected individuals. SARS-CoV RNA levels showed a maximum in fecal samples up to 14 days after the onset of the illness (in one case, fecal samples tested positive for the virus for up to 73 days after the illness onset) [63]. Therefore, it is probable that sewage sludge from an area with infected people can contain SARS-CoV-2 RNA [15]. However, the survival of SARS-CoV-2 in biosolids would be very low at temperatures higher than 20 °C [25]. Actually, there is no evidence for transmission of SARS-CoV-2 via solid waste [64].
5. Wastewater-based epidemiology of the SARS-CoV-2
The study of the several compounds in wastewater, such as illicit drugs and biological agents as Hepatitis A virus and Norovirus, have provided early warnings of outbreaks [18,62]. For this reason, the quantification of SARS-CoV-2 in wastewater affords the ability to monitor the prevalence of the virus among the population via WBE [39], which is a promising strategy for monitoring the spread of SARS-CoV-2 (or resurgence). The basic principle of WBE is that sewage can be used as an indicator of the scale of infected inhabitants, and their use will boost worldwide attention and interest in WBE. However, there are some limitations in the WBE application for COVID-19 pandemic, specially the related to the RNA excretion assumptions of the virus. An example is that not all COVID-19 positive patients excrete SARS-CoV-2 in feces [21]. Another issue is that concentration of the titers in stool varies between patients and there is no evidence that such concentrations are potentially infectious [12]. Estimates of viral load in stool from positive patients are also unclear. A couple of recent publications suggest levels of 600,000 genomic units per mL of fecal material [65] and 30 000 000 genomic units per mL of fecal material [66]. Hence, to strengthen the WBE of the COVID-19, insights about the rate of excretion of genomic units via feces per patient, as well as the persistence of the titer in the wastewater media is demanded.
Another concern for the validation of WBE for COVID-19 spread is the SARS-CoV-2 RNA prevalence in the wastewater. The time for 90 % titer reduction of RNA quantification (T90) in wastewater is dependent on temperature with 27.8, 20.4, 12.6, 8.04 days at 4, 15, 25 and 37 °C, respectively [27]. A similar T90 value of 26 days resulted at low RNA titers at 20 °C [60]. In those studies, the decay rate constant (k) of SARS-CoV-2 RNA ranged from 0.08 to 0.29 ·day−1, when the k values were log10-transformed and linear regression was used to characterize the relationship between temperature (from 4 to 37 °C) and first-order decay rate constant [27,60]. These k values imply that RNA could be detected at least 4 days after its shedding in sewage. In addition to the decay rate of the virus, proper sampling, and sample preserving and transportation temperature, the hydraulic retention time of the sewer distribution system should be considered in the WBE studies. Therefore, the WBE application’s key-factor will be the development of a robust protocol for SARS-CoV-2 detection in wastewater, focusing on the effective concentration methods before the subsequent RNA extraction and RT-qPCR detection [67].
WBE has demonstrated the feasibility of being used as an inexpensive technique to monitor and manage the health and behavior of human populations. Simulations with data from 2017 obtained in 13,940 WWTP of USA demonstrated the potential sensitivity of WBE for generating skewed data [68]. WBE has also been used as a tool to monitor drugs consumption or exposure to environmental and food contaminants. For example, it has been applied to estimate tobacco consumption in seven regions of Spain, reporting the differences in regional consumption. However, no conclusive correlation was found between those values and the prevalence data taken from two different national surveys, nor sociodemographic and health data [69]. WBE can be a powerful tool for specific cases as the COVID-19 using WWTP data but need to be complemented with other indicators to assess the disease accurately, including the correct characterization of the sewage system (maps, flows, etc.) and the existing clinical results.
Few studies present consistent results of COVID-19 surveillance using WBE. For instance, in Southeastern Virginia, USA, the RNA data from weekly samples of nine WWTPs presented spatially and temporally, with regional loading estimates over time, were considered as viable way to describe the occurrence and trends (onset) in SARS-CoV-2 infection [7]. However, the lack of a reliable SARS-CoV-2 stool shedding rate is the current limitation in the use of WBE to estimate total infection within a community [7]. The authors recommend future work to examine the lead-lag association between SARS-CoV-2 wastewater data and regional confirmed clinical data. With a similar aim, a technical bulletin of SARS-CoV-2 RNA surveillance from sewage at Belo Horizonte, Brazil, correlated the reported COVID-19 cases, with the estimated cases, using the typical viral load from sick individuals and the genomic viral copies from sewage [70]. The trend of RNA concentration in sewage allowed to infer that prevalence of COVID-19 was higher than the confirmed cases by local health authorities. Furthermore, percentage of infected people were estimated by regional maps, delimited by the 15 monitored sewage sub-basins, where concern areas were identified due to the increasing RNA concentration in the sewage [70]. Another study in the New Haven, Connecticut, USA metropolitan area, showed that SARS-CoV-2 RNA concentration in primary sludge of WWTP wastewater treatment facilities, was up to 8 days ahead from the SARS-CoV-2 positive test results by reporting date [71].
6. Perspectives for the wastewater treatment post-COVID-19
The presence of SARS-CoV-2 in wastewater generates concerns for the WWTP in the future: i) Occurrence of new pollutants in WWTP, ii) Efficient disinfection and sanitary concerns for the presence of the virus in WWTP, iii) Wastewater management to protect public health and environment, and iv) Implementation of WWTP results in the WBE for monitor of COVID-19.
The development of new drugs and treatments for the COVID-19 (e.g., Remdesivir, hydroxychloroquine (HCQ), chloroquine (CQ), among others), will increase their occurrence in wastewater treatment facilities. CQ and HCQ compounds could be risky for the environment and should be classified as harmful to aquatic organisms [72,73]. In the case of CQ, there are not reports about the occurrence or fate of this compound in the conventional wastewater treatment plants. However, Lindroos et al. [74] reported the degradation of CQ as a pharmaceutical compound model, with efficiencies higher than 98 % in 20 h, using a membrane bioreactor.
For the case of anti-viral drugs, the European Medicines Evaluation Agency has recommended for compassionate use of the Remdesivir, although information on the related environmental risk, such as ecotoxicity and degradability in the environment, is lacking [72]. This means that research related to the persistence of this drug in wastewater will be an important topic to consider facing the new normality. It is also necessary to evaluate the role of the SARS-CoV-2 as an environmental contaminant and its relation to other viral contaminants. Water management should consider the presence of enteric viruses such as SARS-CoV-2 to protect public health though the water supply and the environment.
The SARS-CoV-2 is a serious concern for the irrigation industry, particularly for the wastewater stakeholders of the world. The irrigation with treated wastewater has low risk, since. Gundy et al. [30], for the case of SARS-CoV, reported that survival of the coronaviruses in wastewater is between 2–4 d, and survival in primary wastewater was only slightly longer than secondary wastewater, probably due to the higher level of suspended solids that offer protection from inactivation. Regarding SARS-CoV-2 prevalence in wastewater, half-life mean was 0.64 day, and 4.3 days required for 99 % reduction of infectious virus titers [60]. It should be noted that in developing countries, the unregulated use of wastewater for irrigation needs to be considered for the WBE. In this case, methods for irrigation with wastewater without proper treatment may be advised to operate with caution to avoid contact of SARS-CoV-2. Currently, there is no evidence confirming the survival of SARS-CoV-2 virus after the disinfection process for both drinking water treatment plant and centralized WWTP [21,24,75]. However, a recent study performed by Zhang et al. [76] reported the presence of SARS-CoV-2 RNA in septic tanks after disinfection with 800 g m−3 of sodium hypochlorite in medical wastewater. Since medical wastewater may concentrate the SARS-CoV-2 RNA, disinfection of treated effluent in medical WWTP should follow specific guidelines that include the concentration of SARS-CoV-2 RNA copy number in such water matrix.
The existing disinfection guideline for centralized disinfection of the World Health Organization [75], suggests a concentration of free chlorine ≥ 0.5 mg L−1 after at least 30 min of contact time at pH < 8.0 [75] in order to ensure a complete inactivation of SARS-CoV-2 in all the centralized treatment systems. As it was reported for the medical WWTP, the disinfection process must be tested and optimized for the SARS-CoV-2 efficient inactivation depending on the wastewater source. The disinfection process in the conventional WWTPs (e.g. adsorption, advanced oxidation processes, ozonation, chlorination, ultraviolet light, and membrane from ultrafiltration to reverse osmosis) applied previously to inactivate other coronaviruses can be applied, but better understanding of the efficacy of such technologies for SARS-CoV-2 inactivation is needed [77]. Membrane technology has been applied from long time to remove the virus from water [78]. Currently, membrane technology has been combined with catalytic electrospun [79] and electrocoagulation [80] for virus capture, control and remediation from water at lab scale experiments. There are also approaches that focus in the adsorption of the virus through cell culture [81] and polysaccharide-based resins [82]. However, protocols during drinking water treatment focused on disinfecting from SARS-CoV-2 are missing [83]. The disinfection step in WWTP and drinking water treatment could be the key-process to assure the removal or inactivation of SARS-CoV-2 in wastewater and drinking water, respectively.
The implementation of WBE will be a key-tool for surveillance, assessing, and managing the pandemic. Besides the enhancements in virus concentration and molecular analysis for the detection of SARS-CoV-2, the WBE will employ computational analysis and modeling to examine the feasibility, economy, opportunities and challenges of enumerating active coronavirus infections locally and globally [59]. WBE can contribute to solve the pressing problem of insufficient diagnostic testing and provide a cheap and early warning method for future COVID-19 outbreaks [22]. WBE can also be used as a tool for the decision of the post-isolation phase (restarting activities and finishing the isolation if the population), reinstatement of isolation facing a rebound or seasonal re-emergence, as earlier alert-tool without random-diagnostic testing [84], and as a pre-screening tool to better target clinical testing needs in communities with limited resources [7]. WBE may represent the only viable means of effective surveillance for low-income regions [59], such as Latin-American, Caribbean, Central and South Africa regions, which are emerging as the epicenter of the pandemic [1]. In addition, the majority of these countries present low coverage in sanitation facilities [34]; hence WBE can also be addressed by monitoring surface water such as urban rivers.
Interdisciplinary studies that include epidemiological, environmental, social, and economic interaction, as well as transformative innovation are necessary to create strategies to new challenges in the new normality, including the current second wave for some countries. Finally, the improvement of the sensitivity of techniques for the detection and quantification of the virus in wastewater, especially the concentration methods and PCR amplification, and their international validation, are key factors to implement the WBE.
CRediT authorship contribution statement
Pabel Cervantes-Avilés: Conceptualization, Investigation, Formal analysis, Validation, Writing - original draft, Writing - review & editing. Iván Moreno-Andrade: Investigation, Formal analysis, Validation, Writing - review & editing. Julián Carrillo-Reyes: Investigation, Formal analysis, Validation, Writing - review & editing.
Declaration of Competing Interest
The authors report no declarations of interest.
Acknowledgements
The authors acknowledge the funding of PAPIIT DGAPA-UNAMprojects IV200321 and IN105220.
References
- 1.WHO . WHO; 2020. World Health Organization Coronavirus Disease (COVID-19) Dashboard [WWW Document] [WWW Doc. [Google Scholar]
- 2.Zhai P., Ding Y., Wu X., Long J., Zhong Y., Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int. J. Antimicrob. Agents. 2020;55 doi: 10.1016/j.ijantimicag.2020.105955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yan L., Zhang H.-T., Goncalves J., Xiao Yang, Wang M., Guo Y., Sun C., Tang X., Jing L., Zhang M., Huang X., Xiao Ying, Cao H., Chen Y., Ren T., Wang F., Xiao Yaru, Huang S., Tan X., Huang N., Jiao B., Cheng C., Zhang Y., Luo A., Mombaerts L., Jin J., Cao Z., Li S., Xu H., Yuan Y. An interpretable mortality prediction model for COVID-19 patients. Int. J. Mach. Intell. Sens. Signal Process. 2020;2:283–288. doi: 10.1038/s42256-020-0180-7. [DOI] [Google Scholar]
- 4.CDC . 2020. 2019-Novel Coronavirus (2019-nCoV) Real-Time rRT-PCR Panel Primers and Probes Note : Oligonucleotide Sequences Are Subject to Future Changes as the 2019-Novel Coronavirus. [WWW Document]. Div. Viral Dis. Centers Dis. Control Prev. URL https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-primer-probes.pdf (Accessed 30 June 2020) [Google Scholar]
- 5.Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K.W., Bleicker T., Brünink S., Schneider J., Schmidt M.L., Mulders D.G.J.C., Haagmans B.L., Van Der Veer B., Van Den Brink S., Wijsman L., Goderski G., Romette J.L., Ellis J., Zambon M., Peiris M., Goossens H., Reusken C., Koopmans M.P.G., Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25:1–8. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nalla A.K., Casto A.M., Huang M.L.W., Perchetti G.A., Sampoleo R., Shrestha L., Wei Y., Zhu H., Jerome K.R., Greninger A.L. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J. Clin. Microbiol. 2020;58:1–6. doi: 10.1128/JCM.00557-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gonzalez R., Curtis K., Bivins A., Bibby K., Weir M.H., Yetka K., Thompson H., Keeling D., Mitchell J., Gonzalez D. COVID-19 surveillance in Southeastern Virginia using wastewater-based epidemiology. Water Res. 2020;186 doi: 10.1016/j.watres.2020.116296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Medema G., Heijnen L., Elsinga G., Italiaander R., Brouwer A. Presence of SARS-coronavirus-2 RNA in sewage and correlation with reported COVID-19 prevalence in the early stage of the epidemic in the Netherlands. Environ. Sci. Technol. Lett. 2020;7(7):511–516. doi: 10.1021/acs.estlett.0c00357. [DOI] [PubMed] [Google Scholar]
- 9.Orive G., Lertxundi U., Barcelo D. Early SARS-CoV-2 outbreak detection by sewage-based epidemiology. Sci. Total Environ. 2020;732 doi: 10.1016/j.scitotenv.2020.139298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Falzone L., Musso N., Gattuso G., Bongiorno D., Palermo C.I., Scalia G., Libra M., Stefani S., Unit E., Istituto I., Tumori N., Pascale F.G., Naples I. Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection. Int. J. Mol. Med. 2020:957–964. doi: 10.3892/ijmm.2020.4673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lo I.L., Lio C.F., Cheong H.H., Lei C.I., Cheong T.H., Zhong X., Tian Y., Sin N.N. Evaluation of sars-cov-2 rna shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int. J. Biol. Sci. 2020;16:1698–1707. doi: 10.7150/ijbs.45357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Amirian E.S. Potential fecal transmission of SARS-CoV-2: current evidence and implications for public health. Int. J. Infect. Dis. 2020;95:363–370. doi: 10.1016/j.ijid.2020.04.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., Yin H., Xiao Q., Tang Y., Qu X., Kuang L., Fang X., Mishra N., Lu J., Shan H., Jiang G., Huang X. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;5:434–435. doi: 10.1016/S2468-1253(20)30083-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhang W., Du R.H., Li B., Zheng X.S., Yang, Lou X., Hu B., Wang Y.Y., Xiao G.F., Yan B., Shi Z.L., Zhou P. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg. Microbes Infect. 2020;9:386–389. doi: 10.1080/22221751.2020.1729071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Collivignarelli M.C., Collivignarelli C., Carnevale Miino M., Abbà A., Pedrazzani R., Bertanza G. SARS-CoV-2 in sewer systems and connected facilities. Process Saf. Environ. Prot. 2020;143:196–203. doi: 10.1016/j.psep.2020.06.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Farkas K., Hillary L.S., Malham S.K., Mcdonald J.E., David L. Wastewater and public health: the potential of wastewater surveillance for monitoring COVID-19. Curr. Opin. Environ. Sci. Heal. 2020;17:14–20. doi: 10.1016/j.coesh.2020.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kitajima M., Ahmed W., Bibby K., Carducci A., Gerba C.P., Hamilton K.A., Haramoto E., Rose J.B. SARS-CoV-2 in wastewater: state of the knowledge and research needs. Sci. Total Environ. 2020 doi: 10.1016/j.scitotenv.2020.139076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Been F., Rossi L., Ort C., Rudaz S., Delémont O., Esseiva P. Population normalization with ammonium in wastewater-based epidemiology: application to illicit drug monitoring. Environ. Sci. Technol. 2014;48:8162–8169. doi: 10.1021/es5008388. [DOI] [PubMed] [Google Scholar]
- 19.O’Brien E., Nakyazze J., Wu H., Kiwanuka N., Cunningham W., Kaneene J.B., Xagoraraki I. Viral diversity and abundance in polluted waters in Kampala, Uganda. Water Res. 2017;127:41–49. doi: 10.1016/j.watres.2017.09.063. [DOI] [PubMed] [Google Scholar]
- 20.Mallapaty S. How sewage could reveal true scale of coronavirus outbreak. Nature. 2020;580:176–177. doi: 10.1038/d41586-020-00965-x. [DOI] [PubMed] [Google Scholar]
- 21.Randazzo W., Truchado P., Cuevas-Ferrando E., Simón P., Allende A., Sánchez G. SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water Res. 2020;181 doi: 10.1016/j.watres.2020.115942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Barcelo D. An environmental and health perspective for COVID-19 outbreak: meteorology and air quality influence, sewage epidemiology indicator, hospitals disinfection, drug therapies and recommendations. J. Environ. Chem. Eng. 2020;8 doi: 10.1016/j.jece.2020.104006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Thompson J.R., Nancharaiah Y.V., Gu X., Lee W.L., Rajal V.B., Haines M.B., Girones R., Ng L.C., Alm E.J., Wuertz S. Making waves: wastewater surveillance of SARS-CoV-2 for population-based health management. Water Res. 2020;184 doi: 10.1016/j.watres.2020.116181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sherchan S.P., Shahin S., Ward L.M., Tandukar S., Aw T.G., Schmitz B., Ahmed W., Kitajima M. First detection of SARS-CoV-2 RNA in wastewater in North America: a study in Louisiana, USA. Sci. Total Environ. 2020;743 doi: 10.1016/j.scitotenv.2020.140621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Carraturo F., Del Giudice C., Morelli M., Cerullo V., Galdiero E., Guida M. Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces. Environ. Pollut. 2020 doi: 10.1016/j.envpol.2020.115010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wu F., Zhang J., Xiao A., Gu X., Lee W.L., Armas F., Kauffman K., Hanage W., Matus M., Ghaeli N., Endo N., Duvallet C., Poyet M., Moniz K., Washburne A.D., Erickson T.B., Chai P.R., Thompson J., Alm E.J. SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases. mSystems. 2020;5:1–13. doi: 10.1128/mSystems.00614-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ahmed W., Bertsch P.M., Bibby K., Haramoto E., Hewitt J., Huygens F., Gyawali P., Korajkic A., Riddell S., Sherchan S.P., Simpson S.L., Sirikanchana K., Symonds E.M., Verhagen R., Vasan S.S., Kitajima M., Bivins A. Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA in untreated wastewater to inform application in wastewater-based epidemiology. Environ. Res. 2020;191 doi: 10.1016/j.envres.2020.110092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.La Rosa G., Iaconelli M., Mancini P., Bonanno Ferraro G., Veneri C., Bonadonna L., Lucentini L., Suffredini E. First detection of SARS-CoV-2 in untreated wastewaters in Italy. Sci. Total Environ. 2020;736 doi: 10.1016/j.scitotenv.2020.139652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Prado T., Fumian T.M., Mannarino C.F., Maranhão A.G., Siqueira M.M., Miagostovich M.P. Preliminary results of SARS-CoV-2 detection in sewerage system in Niterói municipality, Rio de Janeiro, Brazil. Mem. Inst. Oswaldo Cruz. 2020;115:115–117. doi: 10.1590/0074-02760200196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gundy P.M., Gerba C.P., Pepper I.L. Survival of coronaviruses in water and wastewater. Food Environ. Virol. 2009;1:10–14. doi: 10.1007/s12560-008-9001-6. [DOI] [Google Scholar]
- 31.Wang X.W., Li J.S., Jin M., Zhen B., Kong Q.X., Song N., Xiao W.J., Yin J., Wei W., Wang G.J., Si B.Y., Guo B.Z., Liu C., Ou G.R., Wang M.N., Fang T.Y., Chao F.H., Li J.W. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J. Virol. Methods. 2005;126:171–177. doi: 10.1016/j.jviromet.2005.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Green M.R., Sambrook J. How to win the battle with RNase. Cold Spring Harb. Protoc. 2019;2019 doi: 10.1101/pdb.top101857. pdb.top101857. [DOI] [PubMed] [Google Scholar]
- 33.Rimoldi S.G., Stefani F., Gigantiello A., Polesello S., Comandatore F., Mileto D., Maresca M., Longobardi C., Mancon A., Romeri F., Pagani C., Moja L., Gismondo M.R., Salerno M. Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers. medRxiv. 2020;1 doi: 10.1101/2020.05.01.20086009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Guerrero-Latorre L., Ballesteros I., Villacrés-Granda I., Granda M.G., Freire-Paspuel B., Ríos-Touma B. SARS-CoV-2 in river water: implications in low sanitation countries. Sci. Total Environ. 2020;743 doi: 10.1016/j.scitotenv.2020.140832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Haramoto E., Malla B., Thakali O., Kitajima M. First environmental surveillance for the presence of SARS-CoV-2 RNA in wastewater and river water in Japan. Sci. Total Environ. 2020;737 doi: 10.1016/j.scitotenv.2020.140405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.WHO Guidelines for environmental surveillance of poliovirus circulation Guidelines for environmental. Vaccine Biol. 2003:03. [Google Scholar]
- 37.Wurtzer S., Marechal V., Mouchel J.-M., Maday Y., Teyssou R., Richard E., Almayrac J.L., Moulin L. Evaluation of lockdown impact on SARS-CoV-2 dynamics through viral genome quantification in Paris wastewaters. medRxiv. 2020 doi: 10.1101/2020.04.12.20062679. 2020.04.12.20062679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ye Y., Ellenberg R.M., Graham K.E., Wigginton K.R. Survivability, partitioning, and recovery of enveloped viruses in untreated municipal wastewater. Environ. Sci. Technol. 2016;50:5077–5085. doi: 10.1021/acs.est.6b00876. [DOI] [PubMed] [Google Scholar]
- 39.Ahmed W., Angel N., Edson J., Bibby K., Bivins A., O’Brien J.W., Choi P.M., Kitajima M., Simpson S.L., Li J., Tscharke B., Verhagen R., Smith W.J.M., Zaugg J., Dierens L., Hugenholtz P., Thomas K.V., Mueller J.F. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci. Total Environ. 2020;728 doi: 10.1016/j.scitotenv.2020.138764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Rusiñol M., Martínez-Puchol S., Forés E., Itarte M., Girones R., Bofill-Mas S. Concentration methods for the quantification of coronavirus and other potentially pandemic enveloped virus from wastewater. Curr. Opin. Environ. Sci. Heal. 2020;17:21–28. doi: 10.1016/j.coesh.2020.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ikner L.A., Soto-Beltran M., Bright K.R. New method using a positively charged microporous filter and ultrafiltration for concentration of viruses from tap water. Appl. Environ. Microbiol. 2011;77:3500–3506. doi: 10.1128/AEM.02705-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Iqbal M., Tao Y., Xie S., Zhu Y., Chen D., Wang X., Huang L., Peng D., Sattar A., Abu M., Shabbir B., Hussain H.I., Ahmed S., Yuan Z. Aqueous two-phase system (ATPS): an overview and advances in its applications. Biol. Proced. Online. 2016:1–18. doi: 10.1186/s12575-016-0048-8. Online. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ahmed W., Bertsch P.M., Bivins A., Bibby K., Farkas K., Gathercole A., Haramoto E., Gyawali P., Korajkic A., McMinn B.R., Mueller J.F., Simpson S.L., Smith W.J.M., Symonds E.M., Thomas K.V., Verhagen R., Kitajima M. Comparison of virus concentration methods for the RT-qPCR-based recovery of murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater. Sci. Total Environ. 2020;739 doi: 10.1016/j.scitotenv.2020.139960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., Penzar D., Perlman S., Poon L.L.M., Samborskiy D.V., Sidorov I.A., Sola I., Ziebuhr J. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181–192. doi: 10.1038/s41579-018-0118-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.La Rosa G., Bonadonna L., Lucentini L., Kenmoe S., Suffredini E. Coronavirus in water environments: occurrence, persistence and concentration methods – a scoping review. Water Res. 2020;179 doi: 10.1016/j.watres.2020.115899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Green H., Wilder M., Collins M., Fenty A., Gentile K., Brittany L., Zeng T., Middleton F.A., Larsen D.A. Quantification of SARS-CoV-2 and cross-assembly phage (crAssphage) from wastewater to monitor coronavirus transmission within communities. medRxiv. 2020;2:1–18. [Google Scholar]
- 48.Mohan S.V., Hemalatha M., Kopperi H., Ranjith I., Kumar A.K. SARS-CoV-2 in environmental perspective : occurrence, persistence, surveillance, inactivation and challenges. Chem. Eng. J. 2021;405 doi: 10.1016/j.cej.2020.126893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Suo T., Liu X., Feng J., Guo M., Hu W., Guo D., Ullah H., Yang Y., Zhang Qiuhan, Wang X., Sajid M., Huang Z., Deng L., Chen T., Liu F., Xu K., Liu Yuan, Zhang Qi, Liu Yingle, Xiong Y., Chen G., Lan K., Chen Y. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens. Emerg. Microbes Infect. 2020;9:1259–1268. doi: 10.1080/22221751.2020.1772678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Mao X., Liu C., Tong H., Chen Y., Liu K. Principles of digital PCR and its applications in current obstetrical and gynecological diseases. Am. J. Transl. Res. 2019:7209–7222. [PMC free article] [PubMed] [Google Scholar]
- 51.Cowell S.J., Harper S.J., Dawson W.O. Short communication A real-time RT-qPCR assay for the detection of Citrus tatter leaf virus. J. Virol. Methods. 2017;244:29–31. doi: 10.1016/j.jviromet.2017.03.004. [DOI] [PubMed] [Google Scholar]
- 52.Eriksson R., Lowther J., Ellström P., Simonsson M. Comparison between RT droplet digital PCR and RT real-time PCR for quanti fi cation of noroviruses in oysters. Int. J. Food Microbiol. 2018;284:73–83. doi: 10.1016/j.ijfoodmicro.2018.06.022. [DOI] [PubMed] [Google Scholar]
- 53.Sowby R.B. Emergency preparedness after COVID-19: a review of policy statements for the U.S. water sector. Util. Policy. 2020;64 doi: 10.1016/j.jup.2020.101058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kocamemi B.A., Kurt H., Sait A., Sarac F., Saatci A.M., Pakdemirli B. SARS-CoV-2 detection in Istanbul wastewater treatment plant sludges. medRxiv. 2020 doi: 10.1101/2020.05.12.20099358. 2020.05.12.20099358. [DOI] [Google Scholar]
- 55.Westhaus S., Weber F., Schiwy S., Linnemann V., Brinkmann M., Widera M., Greve C., Janke A., Hollert H., Wintgens T., Ciesek S. Detection of SARS-CoV-2 in raw and treated wastewater in Germany – suitability for COVID-19 surveillance and potential transmission risks. Sci. Total Environ. 2021;751 doi: 10.1016/j.scitotenv.2020.141750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Cheung K.S., Hung I.F.N., Chan P.P.Y., Lung K.C., Tso E., Liu R., Ng Y.Y., Chu M.Y., Chung T.W.H., Tam A.R., Yip C.C.Y., Leung K., Fung A.Y., Zhang R.R., Lin Y., Cheng H.M., Zhang A.J.X., To K.K.W., Chan K., Yuen K., Leung W.K. Gastrointestinal manifestations of SARS-CoV-2 infection andVirus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020:81–95. doi: 10.1053/j.gastro.2020.03.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Foladori P., Cutrupi F., Segata N., Manara S., Pinto F., Malpei F., Bruni L., La G. SARS-CoV-2 from faeces to wastewater treatment: what do we know? A review. Sci. Total Environ. 2020;743 doi: 10.1016/j.scitotenv.2020.140444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Auler A.C., Cássaro F.A.M., da Silva V.O., Pires L.F. Evidence that high temperatures and intermediate relative humidity might favor the spread of COVID-19 in tropical climate: a case study for the most affected Brazilian cities. Sci. Total Environ. 2020;729 doi: 10.1016/j.scitotenv.2020.139090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Hart O.E., Halden R.U. Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: feasibility, economy, opportunities and challenges. Sci. Total Environ. 2020;730 doi: 10.1016/j.scitotenv.2020.138875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Bivins A., Greaves J., Fischer R., Yinda K.C., Ahmed W., Kitajima M., Munster V.J., Bibby K. Persistence of SARS-CoV-2 in water and wastewater. Environ. Sci. Technol. Lett. 2020 doi: 10.1021/acs.estlett.0c00730. acs.estlett.0c00730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Schoeman D., Fielding B.C. Coronavirus envelope protein: current knowledge. Virol. J. 2019;16:69. doi: 10.1186/s12985-019-1182-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Nghiem L.D., Morgan B., Donner E., Short M.D. The COVID-19 pandemic: considerations for the waste and wastewater services sector. Case Stud. Chem. Environ. Eng. 2020;1 doi: 10.1016/j.cscee.2020.100006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Wigginton K.R. Emerging investigators series: the source and fate of pandemic viruses in the urban water cycle. Environ. Sci. Water Res. Technol. 2015;1 doi: 10.1039/c5ew00125k. [DOI] [Google Scholar]
- 64.Al Huraimel K., Alhosani M., Kunhabdulla S., Stietiya M.H. SARS-CoV-2 in the environment: modes of transmission, early detection and potential role of pollutions. Sci. Total Environ. 2020;744 doi: 10.1016/j.scitotenv.2020.140946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Zhang N., Gong Y., Meng F., Shi Y., Wang J., Mao P., Chuai X., Bi Y., Yang P., Wang F. Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients. Sci. China Life Sci. 2020;(1) doi: 10.1007/s11427-020-1783-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Wölfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Müller M.A., Niemeyer D., Jones T.C., Vollmar P., Rothe C., Hoelscher M., Bleicker T., Brünink S., Schneider J., Ehmann R., Zwirglmaier K., Drosten C., Wendtner C. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. doi: 10.1038/s41586-020-2196-x. [DOI] [PubMed] [Google Scholar]
- 67.Lu D., Huang Z., Luo J., Zhang X., Sha S. Primary concentration – the critical step in implementing the wastewater based epidemiology for the COVID-19 pandemic: a mini-review. Sci. Total Environ. 2020;747 doi: 10.1016/j.scitotenv.2020.141245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Hart O.E., Halden R.U. Simulated 2017 nationwide sampling at 13,940 major U.S. sewage treatment plants to assess seasonal population bias in wastewater-based epidemiology. Sci. Total Environ. 2020;727 doi: 10.1016/j.scitotenv.2020.138406. [DOI] [PubMed] [Google Scholar]
- 69.Montes R., Rodil R., Rico A., Cela R., González-Mariño I., Hernández F., Bijlsma L., Celma A., Picó Y., Andreu V., de Alda M.L., López-García E., Postigo C., Pocurull E., Marcé R.M., Rosende M., Olivares M., Valcárcel Y., Quintana J.B. First nation-wide estimation of tobacco consumption in Spain using wastewater-based epidemiology. Sci. Total Environ. 2020;741 doi: 10.1016/j.scitotenv.2020.140384. [DOI] [PubMed] [Google Scholar]
- 70.INCT/ANA/COPASA/SES/IGAM . 2020. Estimativa da população infectada pelo novo coronavírus baseada no monitoramento do esgoto: Evolução temporal e espacial em Belo Horizonte «Estimation of the population infected by the new coronavirus based on sewage monitoring: Temporal and spatial evolu [WWW Document] p. 1. URL https://www.ana.gov.br/noticias/total-de-infectados-pelo-coronavirus-em-bh-pode-ser-ate-20-vezes-maior-do-que-casos-confirmados/boletim-tematico1-versaofinal-26jun20.pdf (Accessed 10.14.20) [Google Scholar]
- 71.Peccia J., Zulli A., Brackney D.E., Grubaugh N.D., Kaplan E.H., Casanovas-Massana A., Ko A.I., Malik A.A., Wang D., Wang M., Warren J.L., Weinberger D.M., Arnold W., Omer S.B. Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nat. Biotechnol. 2020;38:1164–1167. doi: 10.1038/s41587-020-0684-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Race M., Ferraro A., Galdiero E., Guida M., Núñez-Delgado A., Pirozzi F., Siciliano A., Fabbricino M. Current emerging SARS-CoV-2 pandemic: potential direct/indirect negative impacts of virus persistence and related therapeutic drugs on the aquatic compartments. Environ. Res. 2020;188 doi: 10.1016/j.envres.2020.109808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ramesh M., Anitha S., Poopal R.K., Shobana C. Evaluation of acute and sublethal effects of chloroquine (C18H26CIN3) on certain enzymological and histopathological biomarker responses of a freshwater fish Cyprinus carpio. Toxicol. Rep. 2018;5:18–27. doi: 10.1016/j.toxrep.2017.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Lindroos M., Hörnström D., Larsson G., Gustavsson M., van Maris A.J.A. Continuous removal of the model pharmaceutical chloroquine from water using melanin-covered Escherichia coli in a membrane bioreactor. J. Hazard. Mater. 2019;365:74–80. doi: 10.1016/j.jhazmat.2018.10.081. [DOI] [PubMed] [Google Scholar]
- 75.WHO . 2020. Water, Sanitation, Hygiene, and Waste Management for the COVID-19 Virus. 23 April 2020. [Google Scholar]
- 76.Zhang D., Ling H., Huang X., Li J., Li W., Yi C., Zhang T., Jiang Y., He Y., Deng S., Zhang X., Wang X., Liu Y., Li G., Qu J. Potential spreading risks and disinfection challenges of medical wastewater by the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA in septic tanks of Fangcang Hospital. Sci. Total Environ. 2020;741 doi: 10.1016/j.scitotenv.2020.140445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Naddeo V., Liu H. Editorial Perspectives: 2019 novel coronavirus (SARS-CoV-2): what is its fate in urban water cycle and how can the water research community respond? Environ. Sci. Water Res. Technol. 2020;6:1213–1216. doi: 10.1039/d0ew90015j. [DOI] [Google Scholar]
- 78.McGahey C., Olivieri V.P. Mechanisms of viral capture by microfiltration. Water Sci. Technol. 1993;27:307–310. doi: 10.2166/wst.1993.0365. [DOI] [Google Scholar]
- 79.Al-Attabi R., Rodriguez-Andres J., Schütz J.A., Bechelany M., des Ligneris E., Chen X., Kong L., Morsi Y.S., Dumée L.F. Catalytic electrospun nano-composite membranes for virus capture and remediation. Sep. Purif. Technol. 2019;229 doi: 10.1016/j.seppur.2019.115806. [DOI] [Google Scholar]
- 80.Tanneru C.T., Chellam S. Mechanisms of virus control during iron electrocoagulation - microfiltration of surface water. Water Res. 2012;46:2111–2120. doi: 10.1016/j.watres.2012.01.032. [DOI] [PubMed] [Google Scholar]
- 81.Opitz L., Lehmann S., Zimmermann A., Reichl U., Wolff M.W. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses. J. Biotechnol. 2007;131:309–317. doi: 10.1016/j.jbiotec.2007.07.723. [DOI] [PubMed] [Google Scholar]
- 82.Junter G.A., Lebrun L. Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance. J. Pharm. Anal. 2020;10:291–312. doi: 10.1016/j.jpha.2020.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Tran H.N., Le G.T., Nguyen D.T., Juang R.-S., Rinklebe J., Bhatnagar A., Lima E.C., Iqbal H.M.N., Sarmah A.K., Chao H.-P. SARS-CoV-2 coronavirus in water and wastewater: a critical review about presence and concern. Environ. Res. 2020 doi: 10.1016/j.envres.2020.110265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Daughton C.G. Wastewater surveillance for population-wide Covid-19: the present and future. Sci. Total Environ. 2020;736 doi: 10.1016/j.scitotenv.2020.139631. [DOI] [PMC free article] [PubMed] [Google Scholar]


